PTEN and thyroid gland carcinoma: In a previous study, the propensity for breast and thyroid cancer as a second primary malignancy was higher in individuals with PTEN mutations (SIR = 8.92 for breast cancer and SIR = 5.83 for thyroid cancer) [2, 51].